ArticleFrontiers in oncology2025

Immunotherapy monotherapy for patients with recurrent nonmetastatic larynx cancer who refuse salvage total laryngectomy.

Courtney Brooke Shires et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.